The crypto market has enjoyed a significant rally in recent times, and the Injective Protocol project is one of the coins that has seen a significant increase in market value.
Following its massive surge in value, the coin experienced a massive 100% pump in 30 days, and investors are excited about its consistent performance.
While it might be a snatch for investors, DeeLance, a new Web3 freelance platform, is also making waves.
Launched in 2018, the Injective Protocol is a blockchain network built for finance.
The platform offers developers unique features, such as plug-and-play financial infrastructure primitives, decentralized bridges, oracles, and a composable smart contract layer with CosmWasm.
This enables developers to build powerful DeFi applications easily and allows anyone to access financial services without an intermediary.
One of the most notable features of this platform is the use of a readily available fully decentralized MEV-resistant on-chain order book.
At press time, the $INJ token is trading at $7.9, indicating an uptrend of 7.2% in the last 24 hours.
While this may appear impressive, its long-term rallies have investors looking for more buying opportunities.
$ INJ's seven-day price performance has seen it rise by 40.61%, while its 30-day monthly growth has been near-perfect, with the digital asset rallying a whopping 94.39%.
According to its three-month performance, the ERC-20 token is currently up 386%, which is quite impressive.
Its long-term indicator, denoted by the 200-day moving average (MA), is trading at $2.69, while its short-term 50-day MA is at $4.58, showing strong potential for the project's continued bullish momentum.
The relative strength index (RSI) has an indicator figure of 77.28, showing
Read more on cryptonews.com